All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
COEPTIS THERAPEUTICS HOLDINGS, INC. Last Reported: 1/31/2024 Stock Symbol: COEP

Business Address

105 BRADFORD ROAD, SUITE 420

WEXFORD , PA US 15090

Mailing Address

105 BRADFORD ROAD, SUITE 420

WEXFORD , PA US 15090
Phone Number: 724-934-6467 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 9/30/2023 6/30/2023 12/31/2022 9/30/2022 6/30/2022 12/31/2021 9/30/2021 6/30/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018
Cash and Cash Equivalents -- -- -- $13,830.00 $84,153.00 $404,345.00 $584,634.00 $644,481.00 $907,184.00 $307.00 -- -- $505.00 $503.00 -- -- --
Accounts Receivable Net Current -- -- $8,075.00 -- -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Current Assets $4,120,476.00 $3,797,288.00 $3,941,733.00 $30,967.00 $122,950.00 $412,678.00 $603,304.00 $691,274.00 $958,999.00 -- -- -- $505.00 -- -- -- --
Property Plant and Equipement $11,615.00 $11,924.00 $12,542.00 -- -- -- -- -- -- -- -- -- -- -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Assets $7,170,767.00 $7,155,699.00 $7,915,689.00 $33,299,182.00 $33,112,032.00 $76,171,459.00 $76,360,175.00 $76,446,235.00 $76,710,203.00 $215,234.00 -- -- $171,545.00 -- -- -- --
Accounts Payable $482,005.00 $395,232.00 $99,021.00 -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accrued Liabilities $298,266.00 $247,341.00 $181,998.00 -- -- -- -- -- $5,000.00 -- -- -- $450.00 -- -- -- --
Total Current Liabilities $2,159,126.00 $4,666,072.00 $3,112,360.00 $4,594,179.00 $4,101,922.00 $7,186,927.00 $6,158,971.00 $10,421,940.00 $2,255,000.00 -- -- -- $155,852.00 -- -- -- --
Long Term Debt $975,000.00 $150,000.00 $150,000.00 -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Deficit $-82,981,905.00 $-76,720,998.00 $-65,739,723.00 $-4,659,632.00 $-4,075,392.00 $-6,799,249.00 $-5,580,667.00 $-5,019,991.00 $-76,533.00 $-9,805.00 -- -- $-9,307.00 -- -- -- --
Total Stockholders' Equity $5,011,641.00 $2,489,627.00 $4,803,329.00 $-4,563,212.00 $-3,978,972.00 $-6,774,249.00 $-5,555,667.00 $5,000,008.00 $5,000,005.00 $15,195.00 $15,245.00 $15,695.00 $15,693.00 $16,903.00 $16,901.00 $17,577.00 $17,927.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $7,170,767.00 $7,155,699.00 $7,915,689.00 $33,299,182.00 $33,112,032.00 $76,171,459.00 $76,360,175.00 $76,446,235.00 $76,710,203.00 $215,234.00 -- -- $171,545.00 -- -- -- --

Statement of Operations

Date 9/30/2023 6/30/2023 12/31/2022 9/30/2022 6/30/2022 12/31/2021 9/30/2021 6/30/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $4,983,349.00 $377,040.00 $20,887.00 -- -- -- -- -- -- -- -- -- -- -- -- -- --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $17,950,241.00 $3,638,031.00 $34,195,964.00 -- -- -- -- -- -- -- -- -- -- -- -- -- --
Loss from Operations $-7,831,431.00 $-10,118,810.00 $-34,195,964.00 $-1,816,254.00 $-852,808.00 $-681,319.00 $-397,223.00 $-297,206.00 $-68,430.00 $-500.00 -- -- $-2,234.00 $-1,026.00 -- -- --
Loss Before Income Taxes $-17,242,182.00 $-10,981,275.00 $-37,574,217.00 -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic $-0.75 $-0.52 $-2.63 -- $-0.03 $1.62 -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic 22,957,402 21,080,395 14,295,678 -- 1,875,000 7,500,000 -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted $-0.75 $-0.14 $-2.63 -- $0.38 -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted 26,650,210 21,808,563 14,295,678 -- 1,875,000 -- 9,375,000 -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 150,000,000 150,000,000 150,000,000 -- -- -- -- -- -- -- -- -- -- -- -- -- --
Common Stock Shares Outstanding 32,991,036 24,396,036 19,566,839 1,875,000 1,875,000 1,875,000 1,875,000 3,333,387 2,498,357 2,156,250 -- -- 2,156,250 -- -- -- --
Common Stock Value $3,299.00 $2,440.00 $1,957.00 $25,000.00 $25,000.00 $25,000.00 $25,000.00 $10,019,999.00 $5,076,538.00 $25,000.00 -- -- $25,000.00 -- -- -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 -- -- -- -- -- -- -- -- -- -- -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 10,000,000 10,000,000 10,000,000 -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 -- -- -- -- -- -- -- -- -- -- -- -- -- --
Share Price -- -- -- $10.19 $10.08 $10.00 $9.95 $9.87 $10.10 $10.10 -- -- -- -- -- -- --
Copyright 2024 PursePoor.com